EMERGE

Business analysis services (including electronic data interchange) for raw and consumable material data in the biopharmaceutical supply chain and manufacturing industry namely conversion of certificates of analysis (CoA) and Certificates of Quality (CoQ) into a machinereadable XML format based on an

Platform as a service [PaaS] for the digital data exchange of raw and consumable material data in the biopharmaceutical supply chain and manufacturing industry namely conversion of certificates of analysis (CoA) and Certificates of Quality (CoQ) into a machine-readable XML format based on an existin

Business analysis services for the biopharmaceutical drug development and production industry; provision of information in business matters for the biopharmaceutical drug development and production industry in digital form (information to be stored and made available via a cloud-based system); compu